Page
%P
6 Result(s)
within
Gianni Binotto
Cancer Research
-
Article
Open AccessA successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements
-
Article
Open AccessDeterminants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib
-
Article
Open AccessHypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience
-
Article
Open AccessRuxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis
-
Article
Open AccessLow low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study
-
Article
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy
There is paucity of evidence-based data on health-related quality of life (HRQOL) outcomes of chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs). We performed a multicenter ...
